US Stock MarketDetailed Quotes

BTTX Better Therapeutics

Watchlist
  • 0.012
  • +0.002+20.00%
15min DelayClose Apr 29 16:00 ET
654.19KMarket Cap-10P/E (TTM)

Better Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.25%-5.94M
24.37%-5.09M
1.57%-8.72M
6.13%-28.93M
60.02%-6.34M
-2.10%-7.01M
-22.69%-6.73M
-238.36%-8.86M
-433.74%-30.82M
-15.85M
Net income from continuing operations
48.60%-5.86M
23.56%-7.59M
3.16%-9.36M
1.43%-39.76M
36.92%-8.77M
8.47%-11.41M
-14.77%-9.93M
-81.28%-9.66M
-531.52%-40.34M
---13.89M
Depreciation and amortization
21.18%841K
22.43%797K
13.88%755K
68.56%2.73M
30.85%721K
31.94%694K
23.76%651K
4,043.75%663K
2,058.67%1.62M
--551K
Deferred tax
----
----
----
--0
----
----
----
----
-200.00%-152K
--0
Other non cash items
----
----
----
----
----
----
----
----
5,255.03%9.74M
--1.61M
Change In working capital
-143.64%-1.35M
-42.93%1.23M
-126.84%-524K
367.98%6.27M
126.88%1.26M
95.88%3.09M
388.64%2.15M
-171.52%-231K
-864.38%-2.34M
---4.68M
-Change in prepaid assets
-62.09%480K
8.82%1.15M
-72.80%337K
144.20%2.04M
42.41%-1.52M
290.66%1.27M
249.65%1.06M
305.47%1.24M
-8,642.59%-4.61M
---2.64M
-Change in payables and accrued expense
-200.22%-1.83M
-92.79%79K
41.43%-861K
85.97%4.23M
236.29%2.78M
-18.60%1.83M
-4.37%1.1M
-258.75%-1.47M
802.38%2.27M
---2.04M
Cash from discontinued investing activities
Operating cash flow
15.25%-5.94M
24.37%-5.09M
1.57%-8.72M
6.13%-28.93M
60.02%-6.34M
-2.10%-7.01M
-22.69%-6.73M
-238.36%-8.86M
-433.74%-30.82M
---15.85M
Investing cash flow
Cash flow from continuing investing activities
117.65%66K
-23.59%-503K
-1,235.90%-521K
-10.18%-1.18M
23.73%-360K
-1,977.78%-374K
-40,800.00%-407K
93.30%-39K
53.54%-1.07M
-472K
Capital expenditure reported
120.23%71K
-33.42%-503K
---495K
-5.71%-1.07M
20.46%-346K
---351K
-37,800.00%-377K
--0
55.59%-1.02M
---435K
Net PPE purchase and sale
78.26%-5K
--0
33.33%-26K
-92.73%-106K
62.16%-14K
-27.78%-23K
---30K
---39K
-223.53%-55K
---37K
Cash from discontinued investing activities
Investing cash flow
117.65%66K
-23.59%-503K
-1,235.90%-521K
-10.18%-1.18M
23.73%-360K
-1,977.78%-374K
-40,800.00%-407K
93.30%-39K
53.54%-1.07M
---472K
Financing cash flow
Cash flow from continuing financing activities
104,550.00%6.28M
11.14%5.72M
-43,600.00%-435K
-92.69%5.28M
-99.75%132K
-99.93%6K
-14.25%5.15M
-99.98%1K
871.55%72.33M
53.66M
Net issuance payments of debt
--0
-108.46%-423K
---435K
-82.56%5M
--0
--0
-16.67%5M
--0
285.16%28.68M
--10M
Proceeds from stock option exercised by employees
--0
-71.72%41K
--0
-99.52%284K
-99.78%132K
--6K
--145K
--1K
--59.05M
--59.05M
Net other financing activities
---444K
----
----
----
----
----
----
----
---15.39M
----
Cash from discontinued financing activities
Financing cash flow
104,550.00%6.28M
11.14%5.72M
-43,600.00%-435K
-92.69%5.28M
-99.75%132K
-99.93%6K
-14.25%5.15M
-99.98%1K
871.55%72.33M
--53.66M
Net cash flow
Beginning cash position
-79.13%6.2M
-80.84%6.07M
-61.20%15.74M
32,880.49%40.57M
590.13%22.31M
1,301.56%29.69M
1,880.80%31.67M
32,880.49%40.57M
-83.75%123K
--3.23M
Current changes in cash
105.45%402K
106.44%128K
-8.76%-9.67M
-161.39%-24.83M
-117.58%-6.57M
-762.48%-7.38M
-483.04%-1.99M
-702.51%-8.89M
6,479.02%40.44M
--37.33M
End cash Position
-70.42%6.6M
-79.13%6.2M
-80.84%6.07M
-61.20%15.74M
-61.20%15.74M
590.13%22.31M
1,301.56%29.69M
1,880.80%31.67M
32,880.49%40.57M
--40.57M
Free cash flow
20.43%-5.88M
21.63%-5.59M
-3.86%-9.24M
5.58%-30.11M
58.97%-6.7M
-7.26%-7.39M
-30.14%-7.13M
-178.02%-8.89M
-294.71%-31.89M
---16.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.25%-5.94M24.37%-5.09M1.57%-8.72M6.13%-28.93M60.02%-6.34M-2.10%-7.01M-22.69%-6.73M-238.36%-8.86M-433.74%-30.82M-15.85M
Net income from continuing operations 48.60%-5.86M23.56%-7.59M3.16%-9.36M1.43%-39.76M36.92%-8.77M8.47%-11.41M-14.77%-9.93M-81.28%-9.66M-531.52%-40.34M---13.89M
Depreciation and amortization 21.18%841K22.43%797K13.88%755K68.56%2.73M30.85%721K31.94%694K23.76%651K4,043.75%663K2,058.67%1.62M--551K
Deferred tax --------------0-----------------200.00%-152K--0
Other non cash items --------------------------------5,255.03%9.74M--1.61M
Change In working capital -143.64%-1.35M-42.93%1.23M-126.84%-524K367.98%6.27M126.88%1.26M95.88%3.09M388.64%2.15M-171.52%-231K-864.38%-2.34M---4.68M
-Change in prepaid assets -62.09%480K8.82%1.15M-72.80%337K144.20%2.04M42.41%-1.52M290.66%1.27M249.65%1.06M305.47%1.24M-8,642.59%-4.61M---2.64M
-Change in payables and accrued expense -200.22%-1.83M-92.79%79K41.43%-861K85.97%4.23M236.29%2.78M-18.60%1.83M-4.37%1.1M-258.75%-1.47M802.38%2.27M---2.04M
Cash from discontinued investing activities
Operating cash flow 15.25%-5.94M24.37%-5.09M1.57%-8.72M6.13%-28.93M60.02%-6.34M-2.10%-7.01M-22.69%-6.73M-238.36%-8.86M-433.74%-30.82M---15.85M
Investing cash flow
Cash flow from continuing investing activities 117.65%66K-23.59%-503K-1,235.90%-521K-10.18%-1.18M23.73%-360K-1,977.78%-374K-40,800.00%-407K93.30%-39K53.54%-1.07M-472K
Capital expenditure reported 120.23%71K-33.42%-503K---495K-5.71%-1.07M20.46%-346K---351K-37,800.00%-377K--055.59%-1.02M---435K
Net PPE purchase and sale 78.26%-5K--033.33%-26K-92.73%-106K62.16%-14K-27.78%-23K---30K---39K-223.53%-55K---37K
Cash from discontinued investing activities
Investing cash flow 117.65%66K-23.59%-503K-1,235.90%-521K-10.18%-1.18M23.73%-360K-1,977.78%-374K-40,800.00%-407K93.30%-39K53.54%-1.07M---472K
Financing cash flow
Cash flow from continuing financing activities 104,550.00%6.28M11.14%5.72M-43,600.00%-435K-92.69%5.28M-99.75%132K-99.93%6K-14.25%5.15M-99.98%1K871.55%72.33M53.66M
Net issuance payments of debt --0-108.46%-423K---435K-82.56%5M--0--0-16.67%5M--0285.16%28.68M--10M
Proceeds from stock option exercised by employees --0-71.72%41K--0-99.52%284K-99.78%132K--6K--145K--1K--59.05M--59.05M
Net other financing activities ---444K-------------------------------15.39M----
Cash from discontinued financing activities
Financing cash flow 104,550.00%6.28M11.14%5.72M-43,600.00%-435K-92.69%5.28M-99.75%132K-99.93%6K-14.25%5.15M-99.98%1K871.55%72.33M--53.66M
Net cash flow
Beginning cash position -79.13%6.2M-80.84%6.07M-61.20%15.74M32,880.49%40.57M590.13%22.31M1,301.56%29.69M1,880.80%31.67M32,880.49%40.57M-83.75%123K--3.23M
Current changes in cash 105.45%402K106.44%128K-8.76%-9.67M-161.39%-24.83M-117.58%-6.57M-762.48%-7.38M-483.04%-1.99M-702.51%-8.89M6,479.02%40.44M--37.33M
End cash Position -70.42%6.6M-79.13%6.2M-80.84%6.07M-61.20%15.74M-61.20%15.74M590.13%22.31M1,301.56%29.69M1,880.80%31.67M32,880.49%40.57M--40.57M
Free cash flow 20.43%-5.88M21.63%-5.59M-3.86%-9.24M5.58%-30.11M58.97%-6.7M-7.26%-7.39M-30.14%-7.13M-178.02%-8.89M-294.71%-31.89M---16.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-3.20%